• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阿尔茨海默病的病理生理学,特别参考“淀粉样蛋白瀑布假说”]

[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].

作者信息

Tamaoka Akira

机构信息

Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

出版信息

Rinsho Byori. 2013 Nov;61(11):1060-9.

PMID:24450113
Abstract

The neuropathological characteristics of the Alzheimer's disease (AD) brain include senile plaques, neurofibrillary tangles and neuronal cell loss extensively recognized in brain cortices. Biochemical studies revealed that senile plaques and neuronfibrillary tangles are composed mainly of amyloid beta protein and highly phosphorylated tau protein, a microtubule-associated protein, respectively. Abeta deposition in senile plaques was previously considered to initiate the pathological cascade of Alzheimer's disease (AD), suggesting that the aggregation of Abeta in insoluble Abeta fibrils plays an important role in its neurotoxicity ('amyloid cascade hypothesis'). However, the concentrations of Abeta required for fibrillization are higher than its physiological concentrations. In addition, cognitive decline in AD patients is not correlated with the levels of senile plaque formation. Currently, AD is believed to begin with synaptic dysfunction caused by soluble Abeta oligomers, playing a more important role in the etiology of AD than insoluble Abeta ibrils ('oligomer hypothesis').

摘要

阿尔茨海默病(AD)大脑的神经病理学特征包括老年斑、神经原纤维缠结以及大脑皮层中广泛存在的神经元细胞丢失。生化研究表明,老年斑和神经原纤维缠结分别主要由淀粉样β蛋白和高度磷酸化的tau蛋白(一种微管相关蛋白)组成。老年斑中的淀粉样β蛋白沉积以前被认为启动了阿尔茨海默病(AD)的病理级联反应,这表明不溶性淀粉样β纤维中淀粉样β蛋白的聚集在其神经毒性中起重要作用(“淀粉样蛋白级联假说”)。然而,形成纤维所需的淀粉样β蛋白浓度高于其生理浓度。此外,AD患者的认知能力下降与老年斑形成水平无关。目前,人们认为AD始于可溶性淀粉样β寡聚体引起的突触功能障碍,在AD的病因中,可溶性淀粉样β寡聚体比不溶性淀粉样β纤维起更重要的作用(“寡聚体假说”)。

相似文献

1
[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].[阿尔茨海默病的病理生理学,特别参考“淀粉样蛋白瀑布假说”]
Rinsho Byori. 2013 Nov;61(11):1060-9.
2
[Involvement of beta-amyloid in the etiology of Alzheimer's disease].β-淀粉样蛋白在阿尔茨海默病病因学中的作用
Brain Nerve. 2010 Jul;62(7):691-9.
3
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.淀粉样蛋白-β 和 tau:阿尔茨海默病发病机制中的扳机和子弹。
JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847.
4
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
5
Alzheimer's disease and amyloid: culprit or coincidence?阿尔茨海默病与淀粉样蛋白:罪魁祸首还是巧合?
Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9.
6
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.人脑中淀粉样β肽聚集和积累的生化阶段及其与症状前和病理前阿尔茨海默病的关系。
Brain. 2014 Mar;137(Pt 3):887-903. doi: 10.1093/brain/awt362. Epub 2014 Feb 10.
7
Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.阿尔茨海默病中的蛋白质聚集:淀粉样β蛋白和τ蛋白及其在阿尔茨海默病发病机制中的潜在作用。
Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2.
8
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.在转基因小鼠中,通过基因手段增加tau蛋白水平并不能调节β淀粉样蛋白病变的发生或进展。
J Neurochem. 2007 Aug;102(4):1053-63. doi: 10.1111/j.1471-4159.2007.04607.x. Epub 2007 Apr 30.
9
A critical analysis of the 'amyloid cascade hypothesis'.对“淀粉样蛋白级联假说”的批判性分析。
Folia Neuropathol. 2014;52(3):211-25.
10
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.可溶性纤维前体tau蛋白和β-淀粉样蛋白在早期人类阿尔茨海默病中出现,并与疾病进展和认知衰退相关。
Acta Neuropathol. 2016 Dec;132(6):875-895. doi: 10.1007/s00401-016-1632-3. Epub 2016 Oct 21.

引用本文的文献

1
Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.慢性脑灌注不足通过激活β/γ-分泌酶促进淀粉样β 级联反应。
Neurochem Res. 2017 Dec;42(12):3446-3455. doi: 10.1007/s11064-017-2391-9. Epub 2017 Aug 24.
2
Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease.用于治疗阿尔茨海默病的氚标记D型对映体肽D3的临床前药代动力学研究
PLoS One. 2015 Jun 5;10(6):e0128553. doi: 10.1371/journal.pone.0128553. eCollection 2015.
3
Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer's disease.
冈田酸:一种研究阿尔茨海默病神经退行性变和再生调节机制的工具。
Neural Regen Res. 2015 Mar;10(3):365-7. doi: 10.4103/1673-5374.153679.
4
Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.炎性小体激活在神经血管单元血管疾病病理生理学中的作用。
Antioxid Redox Signal. 2015 May 1;22(13):1188-206. doi: 10.1089/ars.2014.6126. Epub 2014 Nov 11.